These results suggest that TMEM106B expression in lung cancer cells leads to elevated lysosome production, lysosomal exocytosis, and secretion of lysosomal cathepsins into the ECM that may enhance the invasion, migration and metastasis of the tumor cells. Here, TMEM106B is linked to lung cancer.